CD8A and neoplasm: To functionally confirm that the anti-tumor effects of Arf1-depletion in Lgr5/Apc and MYC-ON mice were indeed dependent on the observed adaptive immune response, we depleted the T lymphocytes after tumor formation by injecting anti-CD4 or anti-CD8 antibodies (Fig. 4).